Figure 2.
Fluorescence emission spectra of (1) FITC-labeled E. coli O111:B4 LPS (5 μM). (2) Decrease in fluorescence observed upon addition of chlorpromazine (20 μM) to the FITC-LPS:AGP complex. (3) FITC-LPS (5 μM) in complex with human AGP (25 μM). (4) FITC-LPS (5 μM) in complex with human AGP (25 μM) in the presence of EDTA (1 mM).